BoNT/D Antibody (KB22): sc-51779

BoNT/D Antibody (KB22) is a mouse monoclonal IgG1 antibody that detects BoNT/D in Clostridium botulinum by immunofluorescence (IF). BoNT/D, or botulinum neurotoxin type D, is a potent neurotoxin produced by the anaerobic bacterium Clostridium botulinum and plays a critical role in the pathogenesis of botulism, a severe paralytic illness. The structure of BoNT/D consists of a heavy chain and a light chain linked by a disulfide bond, which is essential for function. The heavy chain facilitates binding to neuronal cells, while the light chain possesses enzymatic activity that cleaves specific proteins involved in neurotransmitter release. This unique structural arrangement allows BoNT/D to effectively inhibit acetylcholine release at the neuromuscular junction, leading to flaccid paralysis. Understanding BoNT/D structure is crucial for developing therapeutic strategies against botulism and designing safer botulinum toxin derivatives for medical and cosmetic applications. Anti-BoNT/D antibody (KB22) serves as an invaluable tool for researchers studying neurotoxicity mechanisms and molecular interactions involved in synaptic transmission.